Letter: risk factors and impacts of psychological morbidity in young people with inflammatory bowel disease - authors' reply

被引：0
|
作者：
Brooks, A. J. [1 ]
Rowse, G. [2 ]
Ryder, A. [2 ]
Peach, E. J. [2 ]
Corfe, B. M. [3 ]
Lobo, A. J. [1 ]
机构：
[1] Sheffield Teaching Hosp NHS Fdn Trust, Acad Dept Gastroenterol, Royal Hallamshire Hosp, Sheffield, S Yorkshire, England
[2] Univ Sheffield, Clin Psychol Unit, Dept Psychol, Sheffield, S Yorkshire, England
[3] Sch Med, Mol Gastroenterol Res Grp, Acad Unit Surg Oncol, Dept Oncol, Sheffield, S Yorkshire, England
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2016年 / 44卷 / 04期
关键词：
D O I：
10.1111/apt.13719
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：426 / 426
页数：1
相关论文
共 50 条
  • [31] Letter: combination of biologics in inflammatory bowel diseases. Authors' reply
    Yang, Edward
    Panaccione, Nicola
    Whitmire, Natalie
    Dulai, Parambir S.
    Vande Casteele, Niels
    Singh, Siddharth
    Boland, Brigid S.
    Collins, Angelina
    Sandborn, William J.
    Panaccione, Remo
    Battat, Robert
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (03) : 568 - 569
  • [32] Treatment of anaemia in inflammatory bowel disease: authors' reply
    de Silva, A
    Rampton, DS
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (08) : 1274 - 1275
  • [33] Personality factors are important predictors of psychological morbidity in patients with inflammatory bowel disease.
    Sheehan, KM
    Steele, C
    O'Gara, A
    Kelly, AM
    Doherty, E
    Patchett, SE
    Murray, FE
    GASTROENTEROLOGY, 2000, 118 (04) : A121 - A121
  • [34] FREQUENCY OF HEALTH RISK BEHAVIOURS IN YOUNG PEOPLE WITH INFLAMMATORY BOWEL DISEASE
    Brooks, A. J.
    Rowse, G.
    Peach, E. J.
    Ryder, A.
    Narula, P.
    Corfe, B. M.
    Norman, P.
    Lobo, A. J.
    GUT, 2016, 65 : A51 - A51
  • [35] Letter: role of diet in the onset and relapse of inflammatory bowel disease from the patients' perspective - authors' reply
    Spooren, C. E. G. M.
    Pierik, M. J.
    Zeegers, M. P.
    Feskens, E. J. M.
    Masclee, A. A. M.
    Jonkers, D. M. A. E.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (03) : 340 - 341
  • [36] Letter: anti-CTLA-4-associated colitis and inflammatory bowel disease pathogenesis - authors' reply
    Gupta, A.
    De Felice, K. M.
    Loftus, E. V., Jr.
    Khanna, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (08) : 1032 - 1033
  • [37] Letter: low muscle mass and disordered eating as causes of osteopenia in inflammatory bowel disease - authors' reply
    Bryant, R. V.
    Andrews, J. M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (12) : 1304 - 1305
  • [38] Letter: infliximab therapy for patients with inflammatory bowel disease - some unanswered questions. Authors' reply
    Buurman, D. J.
    Maurer, J. M.
    Keizer, R. J.
    Kosterink, J. G. W.
    Dijkstra, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (09) : 1134 - 1134
  • [39] Statin Use and Risk of Inflammatory Bowel Diseases: Authors' Reply
    Lochhead, Paul
    Khalili, Hamed
    Sachs, Michael C.
    Chan, Andrew T.
    Olen, Ola
    Ludvigsson, Jonas F.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (08): : 1403 - 1404
  • [40] Psychological factors associated with inflammatory bowel disease
    Eugenicos, M. P.
    Ferreira, N. B.
    BRITISH MEDICAL BULLETIN, 2021, 138 (01) : 16 - 28
12345